Physician profile
Rami R Rustum
NPI 1881694180
$5,830.39
in general payments reported to CMS, 2019-2025
31 companies · $404 in 2025
The $404 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.18 · 2020: $358 · 2021: $552 · 2022: $2,521 · 2023: $981 · 2024: $921 · 2025: $404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,306.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,303.51 | 2020-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Medtronic, INC. | $362.03 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv |
| Painteq LLC | $271.16 | 2023-2024 | Painteq |
| Stryker Corporation | $213.96 | 2025 | Spinejack, Mild Device Kit |
| Novo Nordisk INC | $201.68 | 2021-2025 | Rybelsus, Ozempic |
| Spr Therapeutics, INC | $181.63 | 2024 | Sprint Pns System |
| Abbvie INC. | $145.37 | 2023 | Botox |
| Spinefrontier, INC. | $130.34 | 2022 | |
| Nevro Corp. | $113.17 | 2019-2021 | |
| Medtronic USA, INC. | $81.69 | 2020 | |
| Amgen INC. | $76.25 | 2021-2023 | Prolia, Evenity |
| Teva Pharmaceuticals USA, INC. | $70.29 | 2020-2021 | |
| Lilly USA, LLC | $69.68 | 2023-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $67.95 | 2024-2025 | |
| Exact Sciences Corporation | $66.62 | 2023-2024 | Cologuard Collection Kit |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $56.00 | 2022 | |
| Curonix LLC | $53.39 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertos Medical, INC. | $37.68 | 2022 | |
| Biodelivery Sciences International, INC. | $36.61 | 2021 | |
| Flowonix Medical Incorporated | $33.68 | 2019 | |
| Saluda Medical Americas, INC. | $32.12 | 2024 | Evoke |
| Stimwave Technologies Incorporated | $25.38 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $25.00 | 2021 | |
| Redhill Biopharma INC. | $24.87 | 2021 | |
| Antares Pharma, INC. | $23.70 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $23.07 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.06 | 2022 | |
| Scilex Pharmaceuticals INC. | $21.64 | 2020 | |
| Fidia Pharma USA INC. | $20.48 | 2020 | |
| Jazz Pharmaceuticals INC. | $20.40 | 2021 | |
| Abbott Laboratories | $18.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rami Rustum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.